Grace Montepiedra

Optimizing the Design of a Pharmacokinetic Trial to Evaluate the Dosing Scheme of a Novel Tuberculosis Drug in Children Living with or without HIV.

Montepiedra G, Svensson EM, Wong WK, Hooker AC.

CPT Pharmacometrics Syst Pharmacol. 2023 Nov 10. PMID: 37946698

Timing of maternal isoniazid preventive therapy on tuberculosis infection among infants exposed to HIV in low-income and middle-income settings: a secondary analysis of the TB APPRISE trial.

Gupta A, Singh P, Aaron L, Montepiedra G, Chipato T, Stranix-Chibanda L, Chanaiwa V, Vhembo T, Mutambanengwe M, Masheto G, Raesi M, Bradford S, Golner A, Costello D, Kulkarni V, Shayo A, Kabugho E, Jean-Phillippe P, Chakhtoura N, Sterling TR, Theron G, Weinberg A.

Lancet Child Adolesc Health. 2023 10. 7(10):708-717. PMID: 37634517

Predictors of TB disease in HIV-exposed children from Southern Africa.

Maritz ER, Montepiedra G, Mitchell CD, Madhi SA, Bobat R, Violari A, Hesseling AC, Cotton MF.

Int J Tuberc Lung Dis. 2023 08 01. 27(8):619-625. PMID: 37491747

Effect of pregnancy versus postpartum maternal isoniazid preventive therapy on infant growth in HIV-exposed uninfected infants: a post-hoc analysis of the TB APPRISE trial.

Cherkos AS, LaCourse SM, Enquobahrie DA, Richardson BA, Bradford S, Montepiedra G, Mmbaga BT, Mbengeranwa T, Masheto G, Jean-Phillippe P, Chakhtoura N, Theron G, Weinberg A, Cassim H, Raesi MS, Jean E, Wabwire D, Nematadzira T, Stranix-Chibanda L, Hesseling AC, Aurpibul L, Gupta A, John-Stewart G.

EClinicalMedicine. 2023 Apr. 58:101912. PMID: 36969345

Prevalence of neurotoxicity symptoms among postpartum women on isoniazid preventive therapy and efavirenz-based treatment for HIV: an exploratory objective of the IMPAACT P1078 randomized trial.

Mandima P, Baltrusaitis K, Montepiedra G, Aaron L, Mathad J, Onyango-Makumbi C, Nyati M, Ngocho J, Chareka G, Ponatshego P, Masheto G, McCarthy K, Jean-Philippe P, Gupta A, Stranix-Chibanda L.

BMC Pregnancy Childbirth. 2023 Jan 17. 23(1):34. PMID: 36650479

Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.

Kirmse B, Hobbs C, Aaron L, Montepiedra G, Summar M, Williams PL, Smith CJ, Van Dyke R, Yu C, Ryckman KK, Borkowsky W.

Pediatr Infect Dis J. 2022 08 01. 41(8):e306-e311. PMID: 35622436

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.

Mathad JS, Savic R, Britto P, Jayachandran P, Wiesner L, Montepiedra G, Norman J, Zhang N, Townley E, Chakhtoura N, Bradford S, Patil S, Popson S, Chipato T, Rouzier V, Langat D, Chalermchockcharoentkit A, Kamthunzi P, Gupta A, Dooley KE.

Clin Infect Dis. 2022 05 03. 74(9):1604-1613. PMID: 34323955

Coordination of inflammatory responses in children with perinatally acquired HIV infection.

Weinberg A, Giganti MJ, Sirois PA, Montepiedra G, Canniff J, Agwu A, Boivin MJ, Kapetanovic S, Abzug MJ.

AIDS. 2022 07 01. 36(8):1117-1127. PMID: 35442223

Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV.

Weinberg A, Aaron L, Montepiedra G, Sterling TR, Browning R, Mmbaga B, Vhembo T, Naik S, Kabugho E, Masheto G, Pahwa S, Mathad JS, LaCourse SM, McCarthy K, Bradford S, Theron G, Costello D, Zimmer B, Pierre MF, Gausi K, Denti P, Haas DW, Gupta A.

Clin Infect Dis. 2021 11 02. 73(9):e3555-e3562. PMID: 32720695

Pharmacometrics meets statistics-A synergy for modern drug development.

Ryeznik Y, Sverdlov O, Svensson EM, Montepiedra G, Hooker AC, Wong WK.

CPT Pharmacometrics Syst Pharmacol. 2021 10. 10(10):1134-1149. PMID: 34318621